NCT04730180View on ClinicalTrials.gov

Comparison of Targeting Methods for Transcranial Magnetic Stimulation Treatment of Depression

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions
Depression
Interventions
DEVICE

Transcranial Magnetic Simulation

Brain stimulation treatment will be performed using FDA-cleared TMS coils according to their intended use of treatment of medication resistant depression by targeting the dorsolateral prefrontal cortex.

DEVICE

Mixed reality neuronavigation

Targeting of the dorsolateral prefrontal cortex will be performed with the help of a mixed reality neuronavigation system.

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT04730180 - Comparison of Targeting Methods for Transcranial Magnetic Stimulation Treatment of Depression | Biotech Hunter | Biotech Hunter